Abstract:Bacteriophages offer a promising alternative to conventional antimicrobial treatments, particularly in cases where such treatments have proven ineffective. While naturally occurring phages serve as viable options for phage therapy, advances in synthetic biology and genome engineering enable precise modifications to phages to enhance their therapeutic potential. One such approach is the introduction of antimicrobial genetic payloads into the phage genome. Conventional practice is to integrate such payloads behind genes expressed at very high levels late in the infection cycle, such as the major capsid gene (cps). Nevertheless, phages engineered to contain antimicrobial payloads are often difficult to obtain. For instance, the high expression of toxic payloads can prematurely halt host metabolism, leading to the failure in assembling viable phage progeny. To potentially expand the range of genes viable as genetic payloads, we developed a method to identify intergenic loci with favorable expression levels. We used the machine learning (ML)-based promoter prediction algorithm PhagePromoter to identify these loci. We then used this information to design a computationally-assisted engineering pipeline for the integration of genomic payloads at these locations. We validated our approach experimentally, engineering phages with bioluminescent reporter payloads at various predicted loci. We used the well characterized, strictly lytic, Staphylococcus aureus-infecting bacteriophage, K, as an engineering scaffold and employed homologous recombination to engineer three recombinant phages containing the reporter payload at different predicted loci throughout the genome. The recombinant phages exhibited expression levels consistent with our computational predictions and showed temporal expression patterns corresponding to their genomic locations in early, middle, or late gene clusters. Our study underscores the potential of integrating computational tools with classical sequence analysis to streamline the phage engineering process. This approach not only facilitates the rational design of phages with targeted payload insertions but also paves the way for high-throughput, automated phage engineering, fostering a new era of personalized phage therapy.

What problem does this paper attempt to address?

The main problem that this paper attempts to solve is to improve the efficiency of gene payload integration and the flexibility of expression regulation in phage engineering. Specifically, the authors developed a computational pipeline to select suitable insertion sites in the phage genome for targeted integration and variable - payload expression. Traditionally, payloads are usually inserted behind structural genes that are highly expressed in the late infection cycle, which may cause the host metabolism to stop prematurely, thus affecting the assembly of phage progeny. Therefore, the researchers hope to predict inter - gene regions with favorable expression levels through machine - learning algorithms to expand the range of genes available for gene payloads and optimize the spatio - temporal expression patterns of the payloads. ### Main Objectives: 1. **Develop Computational Tools**: Use machine - learning algorithms (such as PhagePromoter) to predict insertion sites with suitable expression levels in the phage genome. 2. **Verify Experiments**: Insert the luciferase reporter gene at the selected sites through homologous recombination technology and verify whether the actual expression levels at these sites are consistent with the computational predictions. 3. **Optimize Payload Expression**: By selecting different insertion sites, achieve precise expression of the payload in the early, middle or late infection cycle, thereby enhancing the therapeutic potential of phages. ### Research Background: - **Phage Therapy**: Phages, as an alternative to antibiotics, are particularly suitable for combating multi - drug - resistant bacterial infections. - **Genetic Engineering Challenges**: Natural phages have some limitations, such as the rapid emergence of phage - resistant bacteria and immunogenicity. Genetic engineering can enhance the therapeutic effect of phages. - **Limitations of Existing Methods**: Traditional payload - insertion methods mainly focus on behind highly - expressed genes in the late infection cycle, and this method may affect the survival and reproduction of phages. ### Methods and Technologies: - **Machine - Learning Algorithms**: Use the PhagePromoter algorithm to predict promoter regions in the phage genome. - **Homologous Recombination**: Insert reporter genes (such as luciferase) in the selected promoter regions through homologous recombination technology. - **Experimental Verification**: Verify the expression levels and time patterns of different insertion sites through bioluminescence assays. ### Experimental Results: - **Prediction and Verification**: The computationally predicted promoter regions are highly consistent with the experimentally verified data, indicating the effectiveness of this method. - **Spatio - Temporal Expression Patterns**: The expression patterns of payloads inserted near genes expressed at different time points are as expected, further verifying the accuracy of the method. ### Conclusions: - **Application of Computational Tools**: This study shows how to combine computational tools with traditional sequence analysis to simplify the phage - engineering process and achieve targeted payload insertion and precise expression regulation. - **Future Prospects**: This method not only helps in the rational design of phages with specific payload insertions but also paves the way for high - throughput automated phage engineering and promotes the development of personalized phage therapy. In conclusion, this paper provides a new method to optimize the integration and expression of phage gene payloads by combining computational prediction and experimental verification, providing important support for the clinical application of phage therapy.

Computational pipeline for targeted integration and variable payload expression for bacteriophage engineering.

Phage-Enabled Nanomedicine: from Probes to Therapeutics in Precision Medicine.

CRISPR-Cas9 enables efficient genome engineering of the strictly lytic, broad host-range staphylococcal bacteriophage K

Engineering bacteriophages for enhanced host range and efficacy: insights from bacteriophage-bacteria interactions

Genetic Engineering and Rebooting of Bacteriophages in L-Form Bacteria

Use of Cas9 Targeting and Red Recombination for Designer Phage Engineering

Genetic Engineering of Bacteriophages Against Infectious Diseases

Efficient genome engineering of a virulent bacteriophage using CRISPR-Cas9.

Construction of a genetically modified T7Select phage system to express the antimicrobial peptide 1018

Advance on Engineering of Bacteriophages by Synthetic Biology

Systematic, high-throughput characterization of bacteriophage gene essentiality on diverse hosts

PHEIGES: all-cell-free phage synthesis and selection from engineered genomes

Optimizing bacteriophage engineering through an accelerated evolution platform

Directed Evolution of Replication-Competent Double-Stranded DNA Bacteriophage Toward New Host Specificity.

Engineering Phage Host-Range and Suppressing Bacterial Resistance Through Phage Tail Fiber Mutagenesis

Precise microbiome engineering using natural and synthetic bacteriophages targeting an artificial bacterial consortium

Bacteriophage inspired growth-decoupled recombinant protein production in Escherichia coli.

Bacteriophage genome engineering for phage therapy to combat bacterial antimicrobial resistance as an alternative to antibiotics

Engineering of Bacteriophage T4 Genome Using CRISPR-Cas9.

A Novel Approach for T7 Bacteriophage Genome Integration of Exogenous DNA

Temporal epigenome modulation enables efficient bacteriophage engineering and functional analysis of phage DNA modifications